PALATIN TECHNOLOGIES, INC. Available-for-sale Securities, Amortized Cost Basis
PALATIN TECHNOLOGIES, INC. (PTN) had Available-for-sale Securities, Amortized Cost Basis of $0 as of 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2018-05-14
- 2018-03-31: Available-for-sale Securities, Amortized Cost Basis $0.00.
- 2017-12-31: Available-for-sale Securities, Amortized Cost Basis $0.00.
- 2017-09-30: Available-for-sale Securities, Amortized Cost Basis $262.02K.
- 2017-06-30: Available-for-sale Securities, Amortized Cost Basis $262.02K.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2018-03-31 | $0.00 10-Q · filed 2018-05-14 |
| 2017-12-31 | $0.00 10-Q · filed 2018-02-12 |
| 2017-09-30 | $262.02K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $262.02K 10-Q · filed 2018-05-14 |
| 2017-03-31 | $1.39M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $1.39M 10-Q · filed 2017-02-10 |
| 2016-09-30 | $1.39M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.39M 10-Q · filed 2017-05-15 |
| 2016-03-31 | $1.39M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $1.39M 10-Q · filed 2016-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |